High-throughput and ultra-high-throughput screening: Solution- and cell-based approaches

Current Opinion in Biotechnology

Volumn 11, Issue 1, 2000, Pages 47-53

  Sundberg, Steven A ^a  

^a Caliper Life Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; REAGENT;

BIOCHEMISTRY; CELL CULTURE; CHEMOLUMINESCENCE; DRUG SCREENING; FLUORESCENCE ANALYSIS; IMAGING; NONHUMAN; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER; TECHNIQUE;

EID: 0033964118     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(99)00051-8     Document Type: Review

References (55)

1. Burbaum J. Miniaturization technologies in HTS: how fast, how small, how soon? Drug Discov Today. 3:1998;313-322.
2. Major J. Challenges and opportunities in high throughput screening: implications for new technologies. J Biomol Screening. 3:1998;13-17.
3. Divers M. What is the future of high throughput screening? J Biomol Screening. 4:1999;177-178.
4. Stahl W. What is the future of high throughput screening? J Biomol Screening. 4:1999;117-118.
5. Hill D., Wrigley S., Nisbet L. Novel screen methodologies for identification of new microbial metabolites with pharmacological activity. Adv Biochem Eng Biotechnol. 59:1998;73-121.
6. Zysk J., Baumbach W. Homogeneous pharmacologic and cell-based screens provide diverse strategies in drug discovery: somatostatin antagonists as a case study. Comb Chem High Throughput Screen. 1:1998;171-183.
7. Walsh J. High throughput, mechanism-based screening techniques for discovering novel agrochemicals. J Biomol Screening. 3:1998;175-181.
8. Major J. What is the future of high throughput screening? J Biomol Screening. 4:1999;119.
9. Bosworth N., Towers P. Scintillation proximity assay. Nature. 341:1989;167-168.
10. Sittampalam G., Kahl S., Janzen W. High-throughput screening: advances in assay technologies. Curr Opin Chem Biol. 1:1997;384-391.
11. Bosse R., Garlick R., Brown B., Menard L. Development of nonseparation binding and functional assays for G protein-coupled receptors for high throughput screening: pharmacological characterization of the immobilized CCR5 receptor on FlashPlate. J Biomol Screening. 3:1998;285-292.
12. Graziani F., Aldegheri L., Terstappen G. High throughput scintillation proximity assay for the identification of FKBP-12 ligands. J Biomol Screening. 4:1999;3-7.
13. Kariv I., Stevens M., Behrens D., Oldenburg K. High throughput quantitation of cAMP production mediated by activation of seven transmembrane domain receptors. J Biomol Screening. 4:1999;27-32.
14. Parandoosh Z., Knowles S., Xiao X., Zhao C., David G., Nova M. Synthesis coupled to scintillation proximity affinity screening. J Biomol Screening. 3:1998;293. An interesting application of solid-phase synthesis and scintillation proximity techniques to carry out compound synthesis and screening in an integrated format.
15. Stryer L. Fluorescence energy transfer as a spectroscopic ruler. Annu Rev Biochem. 47:1978;819-846.
16. Abriola L., Chin M., Fuerst P., Schweitzer R., Sills M. Digital imaging as a detection method for a fluorescent protease assay in 96-well and miniaturized assay plate formats. J Biomol Screening. 4:1999;121.
17. Kakiuchi N., Nishikawa S., Hattori M., Shimotohno K. A high throughput assay of the hepatitis C virus nonstructural protein 3 serine proteinase. J Virol Methods. 80:1999;77-84.
18. Grahn S., Kurth T., Ullmann D., Jakubke H. S′ subsite mapping of serine proteases based on fluorescence resonance energy transfer. Biochim Biophys Acta. 1431:1999;329-337. A novel use of fluorescence resonance energy transfer for mapping the S′ subsite specificity of serine proteases.
19. Harrison J., Liu X., Balasubramanian S. Screening for oligonucleotide binding affinity by a convenient fluorescence competition assay. Nucleic Acids Res. 27:1999;14.
20. Jameson D., Sawyer W. Fluorescence anisotropy applied to biomolecular interactions. Methods Enzymol. 246:1995;283-300.
21. Nasir M., Jolley M. Fluorescence polarization: an analytical tool for immunoassay and drug discovery. Comb Chem High Throughput Screen. 2:1999;177-190. A review describing recent applications of fluorescence polarization to replace solid-phase assays in fields ranging from studies of enzyme-catalyzed hydrolysis and protein-protein interactions to DNA diagnostics to high-throughput screening for drug discovery.
22. Bolger R., Wiese T., Ervin K., Nestich S., Checovich W. Rapid screening of environmental chemicals for estrogen receptor binding capacity. Environ Health Perspect. 106:1998;551-557.
23. Seethala R., Menzel R. A fluorescence polarization competition immunoassay for tyrosine kinases. Anal Biochem. 255:1998;257-262.
24. Mathis G. Probing molecular interactions with homogeneous techniques based on rare earth cryptates and fluorescence energy transfer. Clin Chem. 41:1995;1391-1397.
25. Stenroos K., Hurskainen P. Homogeneous time-resolved IL-2-IL-2R alpha assay using fluorescence resonance energy transfer. Cytokine. 10:1998;495-499.
26. Kolb A., Kaplita P., Hayes D., Park Y., Pernell C., Major J., Mathis G. Tyrosine kinase assays adapted to homogeneous time-resolved fluorescence. Drug Discov Today. 3:1998;333-342. An excellent overview of homogenous tyrosine kinase assays using time-resolved fluorescence as the detection method.
27. Moore K., Turconi S., Miles-Williams A., Djaballah H., Hurskainen P., Harrop J., Murray K., Pope A. A homogenous 384-well high throughput screen for novel tumor necrosis factor receptor: ligand interactions using time resolved energy transfer. J Biomol Screening. 4:1999;205-214.
28. Auer M., Moore K., Meyer-Almes F., Guenther R., Pope A., Stoeckli K. Fluorescence correlation spectroscopy: lead discovery by miniaturized HTS. Drug Discov Today. 3:1998;457-465. A review of fluorescence correlation tyrosine kinase assays using time-resolved fluorescence as the detection method.
29. Koltermann A., Kettling U., Bieschke J., Winkler T., Eigen M. Rapid assay processing by integration of dual-color fluorescence cross-correlation spectroscopy: high throughput screening of enzyme activity. Proc Natl Acad Sci USA. 95:1999;1421-1426.
30. Kricka L. Chemiluminescence and bioluminescence. Anal Chem. 71:1999;305R-308R.
31. Creton R., Kreiling J., Jaffe L. Calcium imaging with chemiluminescence. Microsc Res Techique. 46:1999;390-397.
32. Knight A. A review of recent trends in analytical applications of electrogenerated chemiluminescence. Anal Chem. 18:1999;47-62.
33. Pasini P., Musiani M., Russo C., Valenti P., Aicardi G., Crabtree J., Baraldini M., Roda A. Chemiluminescence imaging in bioanalysis. J Pharm Biomed Anal. 18:1998;555-564.
34. Denyer J., Worley J., Cox B., Allenby G., Banks M. HTS approaches to voltage-gated ion channel drug discovery. Drug Discov Today. 3:1998;323-332. A good overview of voltage-gated ion channel screening methods with 33 references.
35. Gonzales J., Oades K., Leychkis Y., Harootunian A., Negulescu P. Cell based assays and instrumentation for screening ion-channel targets. Drug Discov Today. 4:1999;431-439. A good overview of cell-based assay methods for screening against ion channel targets, with a description of recently developed FRET-based voltage sensor dyes.
36. Dias J., Go N., Hart C., Mattheakis L. Genetic recombination as a reporter for screening steroid receptor agonists and antagonists. Anal Biochem. 258:1998;96-102.
37. Sharif T., Sharif M. A novel approach for examining the anti-proliferative effect of protein kinase C inhibitors against human astrocytoma cells. Int J Oncol. 13:1998;685-692.
38. Sharif T., Sharif M. A high throughput system for the evaluation of protein kinase C inhibitors based on Elk1 transcriptional activation in human astrocytoma cells. Int J Oncol. 14:1999;327-335.
39. Grentzmann G., Ingram J., Kelly P., Gesteland R., Atkins J. A dual-luciferase reporter system for studying recoding signals. RNA. 4:1998;479-486.
40. TM high-content screening system. J Biomol Screening. 4:1999;75-86.
41. Carrithers M., Marotti L., Yoshimura A., Lerner M. A melanophore-based screening assay for erythropoietin receptors. J Biomol Screening. 4:1999;9-14.
42. Miraglia S., Swartzman E., Mellentin-Michelotti J., Evangelista L., Smith C., Gunawan I., Lohman K., Goldberg E., Manian B., Yuan P. Homogeneous cell- and bead-based assays for high throughput screening using fluorometric microvolume assay technology. J Biomol Screening. 4:1999;193-204.
43. Bedard J., May S., Barbeau D., Yuen L., Rando R., Bowlin T. A high throughput colorimetric cell proliferation assay for the identification of human cytomegalovirus inhibitors. Antiviral Res. 41:1999;35-43.
44. Kolb A., Neumann K. Beyond the 96-well microplate: instruments and assay methods for the 384-well format. J Biomol Screening. 2:1997;103-109.
45. Comley J., Binnie A., Bonk C., Houston J. A 384-HTS for human Factor VIIa: comparison with 96- and 864-well formats. J Biomol Screening. 2:1997;171-178.
46. Maffia A., Kariv I., Oldenburg K. Miniaturization of a mammalian cell-based assay: luciferase reporter gene readout in a 3 microliter 1536-well plate. J Biomol Screening. 4:1999;137-142.
47. Mere L., Bennett T., Coassin P., England P., Hamman B., Rink T., Zimmerman S., Negulescu P. Miniaturized FRET assays and microfluidics: key components for ultra-high-throughput screening. Drug Discov Today. 4:1999;363-369.
48. Oldenburg K., Zhang J., Chen T., Maffia A., Blom K., Combs A., Chung T. Assay miniaturization for ultra-high throughput screening of combinatorial and discrete compound libraries: a 9600-well (0.2 microliter) assay system. J Biomol Screening. 3:1998;55-62.
49. Chiem N., Harrison J. Microchip-based capillary electrophoresis for immunoassays: analysis of monoclonal antibodies and theophylline. Anal Chem. 69:1997;373-378.
50. Chiem N., Harrison J. Microchip systems for immunoassay: an interated immunoreactor with electrophoretic separation for serum theophylline determination. Can Clin Chem. 44:1998;591-598. Demonstration of a microchip-based immunoassay and electrophoretic separation of the reaction products using monoclonal antibodies and theopylline.
51. Hadd A., Raymond D., Halliwell J., Jacobson S., Ramsey J. Microchip devices for performing enzyme assays. Anal Chem. 69:1997;3407-3412.
52. Hadd A., Jacobson S., Ramsey J. Microfluidic assays of acetylcholinesterase inhibitors. Anal Chem. 71:1999;5206-5212. Demonstration of a low-throughput enzyme inhibition assay carried out in a microchip format.
53. Cohen C., Chin-Dixon E., Jeong S., Nikiforov T. A microchip-based enzyme assay for protein kinase A. Anal Biochem. 273:1999;89-97. Demonstration of a fluorescence-based kinase assay carried out in a microchip format using electrophoretic separation of the reaction product from the fluorescently tagged substrate as the assay read-out.
54. Li P., Harrison J. Transport, manipulation, and reaction of biological cells on-chip using electrokinetic effects. Anal Chem. 69:1997;1564-1568.
55. Andersson P., Li P., Smith R., Szarka R., Harrison J. Biological cell assays on an electrokinetic microchip. Transducers '97, vol 2. 1997;1311-1314 IEEE Press, Piscataway, NJ.